IHS Chemical Week

EnviroTech :: R&D

Bayer HealthCare and Drug Development Company Covance Enter Strategic Partnership

5:45 AM MDT | May 30, 2012 | Natasha Alperowicz

Bayer HealthCare and Covance (Princeton, NJ) will establish a long-term strategic partnership in the area of clinical drug development, including R&D services related to phase II-IV clinical studies and central laboratory services. The new partnership marks the next step in cooperation both partners have developed over the past few years and represents the efforts to maximize its benefits across the Bayer HealthCare organization, Bayer says. Bayer’s goal is to leverage Covance’s broad range of experience and services across the R&D portfolio...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa